Market Incident
Public · Developing
AI compiled from Infoway · 3 analyzed stories
Organigram to Acquire Aurora and Establish a Global Cannabis Leader
Organigram Global agreed to acquire all Aurora Cannabis shares for C$7.80 each, valuing Aurora at about C$561 million. The price is a 93% premium to Aurora's closing price on August 10, 2026, before Curaleaf announced its hostile bid for Aurora.
Published:
Updated:
What happened
Organigram Global has agreed to acquire all shares of Aurora Cannabis for C$7.80 each, valuing the deal at about C$561 million. Both companies’ boards approved the proposed deal. It still needs Aurora shareholders’ approval and is expected to close in January 2027.
Global impact / market context
The proposed price is a 93% premium to Aurora’s August 10, 2026 closing price, before Curaleaf announced its rival hostile bid. The deal could affect what Aurora shareholders receive, but it is not final and still needs their approval.
What to watch
- Check whether Aurora shareholders approve the deal, because their approval is still required.
- Check for updates on Curaleaf’s rival bid, because it is competing with Organigram’s offer.
- Check whether the expected January 2027 closing date changes, because the deal has not yet closed.
Affected assets
- Aurora Cannabis Inc.
- Curaleaf Holdings, Inc.
- Organigram Global Inc.
Evidence
- Infoway News — Organigram Swoops In To Acquire Aurora Cannabis, Topping Curaleaf's Rival Bid – ACB Stock Surges To Over 10-Month Highs
- Infoway News — Organigram to buy Aurora Cannabis amid hostile bid from Curaleaf
- Infoway News — Organigram to Acquire Aurora and Establish a Global Cannabis Leader
- Incident timeline — Organigram Swoops In To Acquire Aurora Cannabis, Topping Curaleaf's Rival Bid – ACB Stock Surges To Over 10-Month Highs
- Incident timeline — Organigram to buy Aurora Cannabis amid hostile bid from Curaleaf
- Incident timeline — Organigram to Acquire Aurora and Establish a Global Cannabis Leader